#Canada #Toronto #Webinar #pharmacogenomics #DPYD Testing

Upcoming Webinar on DPYD Testing Implementation

In an era where precision medicine is becoming increasingly critical, the integration of DPYD testing within healthcare settings is essential. This upcoming webinar, hosted by Xtalks, aims to guide healthcare professionals through the pivotal process of implementing DPYD testing from initial guidelines to active utilization in laboratory settings.

What is DPYD Testing?

DPYD testing focuses on detecting specific genetic variants in the DPYD gene, which plays a crucial role in metabolizing fluoropyrimidine-based drugs. It is particularly significant because certain variants can increase the risk of severe toxicity associated with these therapies. Although the clinical benefits of such testing are acknowledged, the widespread adoption of DPYD testing has encountered several barriers.

Webinar Highlights

During this comprehensive webinar, participants will benefit from expert insights from industry leaders, specifically:

• - A thorough overview of the clinical significance of DPYD testing and the related pharmacogenomics landscape.
• - Discussion of current methodologies for testing, emphasizing evidence linking DPYD variants with elevated toxicity risk.
• - Consensus recommendations for integrating DPYD testing into clinical practice.

The session will focus on identifying operational barriers hindering the implementation of DPYD testing at scale, such as:

• - Provider Education: Gaining acceptance among healthcare providers to routinely order DPYD testing.
• - Electronic Health Record Integration: Streamlining testing processes within existing EHR systems.
• - Reimbursement Policies: Understanding the financial frameworks surrounding DPYD tests to encourage broader use.

Overcoming Challenges

The speakers will provide tailored strategies to tackle these challenges effectively. By leveraging discrete result data and aligning clinical workflows, labs can create smoother paths for ordering, interpretation, and follow-through. Implementing these practices can significantly reduce the friction experienced at the point of care, promoting a standardized approach to DPYD testing.

Expert Panel

Attendees will hear from industry veterans like Emily Morris, MSc CCGC, and Dr. Vicky Pratt, sharing their expertise and insights into real-world applications of pharmacogenomics.

Registration Details

The live webinar is set to take place on March 25, 2026, at 12 PM EDT (5 PM CET). This is a valuable opportunity for professionals in pharmacogenomics and related fields to enhance their understanding and operational capabilities. To register and learn more, visit the Xtalks website.

Join the Community

Xtalks is dedicated to providing healthcare and life science professionals with trusted knowledge to foster innovation and collaboration within the industry. Embrace the future of personalized medicine by participating in this valuable discussion about the integration of DPYD testing into routine laboratory practices. Join us and be part of a transformative movement in healthcare.